PreFree

PreFree by NeoPredics supports healthcare professionals with AI-based, personalized risk predictions and clinical visualizations – for severe maternal or fetal complications associated with hypertensive disorders of pregnancy and for the likelihood of delivery within 14 days before the 34th week of pregnancy.

PreFree

PreFree by NeoPredics supports healthcare professionals with AI-based, personalized risk predictions and clinical visualizations – for severe maternal or fetal complications associated with hypertensive disorders of pregnancy and for the likelihood of delivery within 14 days before the 34th week of pregnancy.

How PreFree works

PreFree uses a multimodal, CE-marked prediction model that combines clinical patient data with the biomarkers sFlt-1 and PlGF to identify serious risks associated with preeclampsia at an early stage. The software provides an individualized risk prediction for the next two weeks and supports healthcare professionals in making informed decisions about further monitoring, potential hospital admission, or safe discharge. Additionally, a digital patient diary enables the structured collection of relevant health data from home.

The application is used in three simple steps:

  • Collecting clinical data: Healthcare professionals enter selected clinical values into the web portal.

  • Calculating risk: Machine learning algorithms calculate risk scores tailored to individual patients.

  • Interpreting results: Results are displayed as a number and as a color-coded category. PreFree supports clinical assessment but does not replace it.

Who is PreFree designed for?

The application is intended for physicians specializing in obstetrics and prenatal medicine, as well as midwives and nurses. Midwives and nurses can enter the data without having to interpret the results medically.

The patient group includes pregnant women aged 18 to 45 with a singleton pregnancy between 20+0 and 40+6 weeks of gestation (WG) who are at increased risk for preeclampsia.

The accompanying PatApp is available for patients.

Important: PreFree is not a standalone diagnostic tool. For exclusion criteria (including severe preeclampsia, HELLP syndrome, eclampsia, and multiple pregnancies), see the instructions for use.

Instructions for use

Please use the user manual that corresponds to your software version. You can find the version in the software’s “Info” menu.

Software Version Language Document Date of Issue
V1.2.2 (current) German Click here December 3, 2025
V1.2.2 (current) English Click here December 8, 2025

Upon request, you will receive a free printed copy of the user manual within 7 calendar days. Please send your request to [email protected] or call +49 6151 8618 0.

A PDF reader is required to open the documents.

Regulatory information

Manufacturer: BAYOOCARE GmbH, Europaplatz 5, 64293 Darmstadt, Germany
Classification: Class IIa medical device according to Regulation (EU) 2017/745 · CE 0123
Basic UDI-DI: 42519815PreFreeWebED
Development & Operation: NeoPredics AG, Regensburg, Germany

Additional Links

Contact us

Are you planning to bring a medical device to market and looking for an experienced contract manufacturer? Contact us for a no-obligation consultation. Together, we’ll develop the right strategy for your medical device.